Aerie Pharmaceuticals reported $-32374000 in Operating Profit for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Profit Change
Adamas Pharmaceuticals ADMS:US -5636000 3.52M
Aerie Pharmaceuticals AERI:US $ -32.37M 0.87M
Amarin AMRN:US $ -13.07M 21.85M
Bluebird Bio BLUE:US $ -216.95M 23.88M
Cara Therapeutics CARA:US $ -1124000 29.75M
Coherus Biosciences CHRS:US $ -32.79M 8.62M
Endo International Ordinary Shares ENDP:US $ 89.16M 53.95M
Flexion Therapeutics FLXN:US $ -23658000 6.78M
Gw Pharmaceuticals GWPH:US $ -21.03M 1.78M
Horizon Pharma HZNP:US $ 331.54M 193.03M
Insmed INSM:US $ -103617000 2.64M
JAZZ PHA JAZZ:US $ 28.37M 97.96M
Merk MRK:US $ 4826M 3212M
Mirati Therapeutics MRTX:US $ -79.5M 84.69M
Novartis NOVN:VX 3.23B 246M
Pacira Pharmaceuticals PCRX:US $ 31.43M 3.41M
Regeneron Pharmaceuticals REGN:US $ 1847.2M 1500M
Revance Therapeutics RVNC:US $ -72723000 2.39M
Supernus Pharmaceuticals SUPN:US $ 32.6M 1.51M
Teva Pharmaceutical Industries TEVA:US $ 623M 41M
Valeant Pharmaceuticals VRX:CN $ 562M 877M
Zoetis ZTS:US $ 659M 23M
Zogenix ZGNX:US $ -53.87M 1.56M